Zyvox (linezolid)

This means it can be used to treat Gram positive bacterial infections that are resistant to other antibiotics. An example of this is infection with the 'superbug' MRSA (methicillin-resistant staphylococcus aureus). Such bacterial infections have become more common, particularly in hospitals, due to increasing resistance of bacteria to antibiotic treatment. As linezolid works in a different way to other antibiotics, it may provide doctors with a new line of attack for these types of infections.

To make sure the bacteria causing an infection are susceptible to linezolid your doctor may take a tissue sample, for example a swab from the skin, or a sputum sample.

Use with caution in

• Decreased kidney function.
• People having haemodialysis for kidney failure.
• Severely decreased liver function.
• Uncontrolled high blood pressure (hypertension).
• Tumour of the adrenal gland (phaeochromocytoma).
• Tumour in the intestine called a carcinoid tumour.
• Thyrotoxicosis.
• Bipolar affective disorder (manic depression).
• Mental disorder with symptoms of schizophrenia and mood disorder.
• Acute states of confusion.
• Anaemia.
• People with low numbers of white blood cells in their blood.
• People with low numbers of cells called platelets in their blood (thrombocytopenia).

Not to be used in

• People who have taken a monoamine-oxidase inhibitor medicine in the last 14 days.
• Breastfeeding.
• Zyvox oral solution contains aspartame, which is a source of phenylalanine, and so is not suitable for people with phenylketonuria.
• Zyvox oral solution also contains sucrose and so is not suitable for people with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.
• This antibiotic is not recommended for children and adolescents under 18 years of age, as there is no information regarding its safety and efficacy in this age group.
• This medicine should not be used if you are allergic to any of its ingredients. Please inform your doctor or pharmacist if you have previously experienced such an allergy.

If you feel you have experienced an allergic reaction, stop using this medicine and inform your doctor or pharmacist immediately.

Pregnancy and breastfeeding

• The safety of this medicine for use during pregnancy has not been established. It is not recommended for use in pregnancy unless considered essential by your doctor. Seek medical advice from your doctor.
• This medicine may pass into breast milk. Mothers who need to take this medicine should not breastfeed their infants during treatment. Discuss with your doctor.

Side effects

Common 

• Headache.
• Diarrhoea.
• Nausea.
• Yeast infection of the moist areas of the body, especially the vagina and mouth (candidiasis).

Uncommon 

• Decreased numbers of red blood cells, haemoglobin, white blood cells or platelets in the blood
• Inflammation of the vagina (vaginitis).
• Difficulty in sleeping (insomnia)
• Pins and needles sensations (paraesthesia) or numbness.
• Blurred vision.
• Sensation of ringing or buzzing in the ears (tinnitus).
• Inflammation of the wall of a vein with a blood clot forming in the affected segment of vein (thrombophlebitis).
• Inflammation of the pancreas (pancreatitis).
• Inflammation of the stomach (gastitis).
• Disturbances of the gut such as constipation, vomiting, abdominal pain, dry mouth, indigestion,
• Discoloration of the tongue.
• Skin reactions such as rash, itching.
• Fever.
• Fatigue.

Rare

• Increased heart rate (tachycardia).
• Sudden loss of brain function with full recovery within 24 hours (transient ischaemic attack).
• Kidney failure.
• Frequency unknown
• Inflammation of the large intestine (colitis).
• Elevated levels of lactic acid in the blood (lactic acidosis).
• Swelling of the optic nerve which results in blurring of vision (optic neuritis).
• Decreased amount of sodium in the blood (hyponatraemia).
• Discoloation of the teeth.
• Hair loss.
• Severe blistering skin reactions, eg Stevens-Johnson Syndrome, toxic epidermal necrolysis.

The side effects listed above may not include all of the side effects reported by the medicine's manufacturer.

For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist.

How can this medicine affect other medicines?

This medicine must not be taken by people who are taking monoamine oxidase inhibitor medicines (MAOIs - used to treat depression or Parkinson's disease), or who have taken an MAOI medicine in the previous two weeks. MAOIs are:

• the antidepressants phenelzine, isocarboxacid or tranylcypromine
• moclobemide for depression
• selegiline or rasagiline for Parkinson's disease.

Linezolid should not be taken by people taking any of the following medicines unless the individual is under close medical observation and their blood pressure is monitored:

• SSRI antidepressants, eg fluoxetine, paroxetine
• tricyclic antidepressants, eg amitriptyline, imipramine
• triptans for migraine, eg sumatriptan, almotriptan, rizatriptan
• decongestants, eg pseudoephedrine, phenylpropanolamine, ephedrine, phenylephrine
• medicines that open the airways, eg salbutamol, salmeterol, terbutaline
• amphetamines
• methylphenidate
• adrenaline
• noradrenaline
• pethidine
• buspirone
• dopamine
• dobutamine.

References:

https://www.myvmc.com/drugs/zyvox/

https://www.netdoctor.co.uk/medicines/infection/a8234/zyvox-linezolid/

https://www.rxlist.com/consumer_linezolid_zyvox/drugs-condition.htm

https://www.medicines.org.uk/emc/product/1688/smpc

https://reference.medscape.com/drug/zyvox-linezolid-342574

https://www.drugbank.ca/drugs/DB00601

https://www.rxlist.com/consumer_linezolid_zyvox/drugs-condition.htm

https://medlineplus.gov/druginfo/meds/a602004.html